Aviva plc Stock Euronext Paris

Equities

AV

GB0002162385

Life & Health Insurance

End-of-day quote Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Aviva plc -.--% -.--%

Financials

Sales 2024 * 42.62B 53.47B 49.95B Sales 2025 * 43.04B 53.99B 50.44B Capitalization 12.56B 15.76B 14.73B
Net income 2024 * 1.16B 1.46B 1.36B Net income 2025 * 1.31B 1.65B 1.54B EV / Sales 2024 * 0.29 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.29 x
P/E ratio 2024 *
11.1 x
P/E ratio 2025 *
9.75 x
Employees -
Yield 2024 *
7.69%
Yield 2025 *
8.21%
Free-Float 95.57%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 57 20-01-01
Director of Finance/CFO - 22-09-04
Chief Tech/Sci/R&D Officer 62 16-12-31
Members of the board TitleAgeSince
Chief Executive Officer 57 20-01-01
Director/Board Member 67 20-11-30
Chairman 61 19-09-24
More insiders
Aviva plc is a United Kingdom-based insurance, wealth, and retirement business company. Its segments include UK & Ireland Insurance, General Insurance, and Aviva Investors, International investments, and Other Operations. The principal activities of UK and Ireland Life operations are life insurance, long-term health and accident insurance, savings, pensions and annuity business. The principal activities of UK & Ireland General Insurance operations are the provision of insurance cover to individuals and businesses for risks associated with motor vehicles, property and liability, and medical expenses. The principal activity of Canada General Insurance operation is the provision of personal and commercial lines insurance products, for risks associated with motor, property and liability distributed through insurance brokers. It also operates Lloyd's platform, encompassing its Corporate Member, Managing Agent, international distribution entities and tenancy rights to Syndicate 1492.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
4.679 GBP
Average target price
5.052 GBP
Spread / Average Target
+7.97%
Consensus

Quarterly revenue - Rate of surprise